DIABETIC NEUROPATHY

✓ Medically ReviewedDISEASEID: MDBT0264🚨 TRIAGE: URGENT

📖

Definition

CLINICAL DEFINITION

Diabetic neuropathy is a heterogeneous group of disorders affecting peripheral somatic and autonomic nerves that arise in the context of diabetes mellitus after exclusion of other causes. The most common form, distal symmetrical polyneuropathy, is a length-dependent sensorimotor polyneuropathy attributable to metabolic and microvessel alterations from chronic hyperglycaemia and cardiovascular risk covariates. Diagnosis is clinical, supported by symptoms and signs of peripheral nerve dysfunction, and is one of exclusion in people with diabetes.

IN PLAIN ENGLISH

Diabetic neuropathy is nerve damage caused by diabetes. It most often affects the feet and legs, causing numbness, tingling, or pain, and can also affect internal organs.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Diabetic neuropathy is NOT a single uniform condition; it encompasses several distinct neuropathic syndromes, and other causes of peripheral neuropathy (such as vitamin B12 deficiency, alcohol-related neuropathy, or monoclonal gammopathy) must be excluded before attributing neuropathy to diabetes.

🔤

Word Breakdown

diabetic

=relating to diabetes mellitus

neuro-

=nerve (from Greek 'neuron')

-pathy

=disease or suffering (from Greek 'pathos')

Literal Meaning: Nerve suffering or disease occurring in the context of diabetes

🏷️

Abbreviations

DPN=Diabetic Peripheral Neuropathy — the most common form, a length-dependent sensorimotor polyneuropathy

DSPN=Distal Symmetrical Polyneuropathy — the typical pattern of DPN

CAN=Cardiovascular Autonomic Neuropathy — autonomic involvement associated with increased mortality

PDPN=Painful Diabetic Peripheral Neuropathy — neuropathic pain arising from DPN

🔄

Synonyms & Variants

Diabetic Polyneuropathy›Diabetic Peripheral Neuropathy›

🎯

Category-Specific Context

As a disease, diabetic neuropathy encompasses a spectrum of diffuse and focal neuropathic syndromes. The diffuse forms include distal symmetrical sensorimotor polyneuropathy (the most common) and autonomic neuropathy; focal forms include mononeuropathies and radiculopathies. The condition is staged by severity and distribution, and its clinical impact ranges from asymptomatic loss of sensation to disabling neuropathic pain and organ dysfunction.

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Diabetes Outpatient ClinicGeneral Medicine WardNeurology ClinicPodiatry ClinicEmergency DepartmentPrimary Care

USAGE & DOCUMENTATION NOTES

In clinical documentation, the term is often qualified by the syndrome (e.g., 'painful diabetic peripheral neuropathy', 'cardiovascular autonomic neuropathy'). Screening findings are recorded as presence or absence of protective sensation (10 g monofilament) and vibration perception (128 Hz tuning fork). Examination notes typically describe the distribution (stocking-and-glove) and the modalities affected (small-fibre: pinprick/temperature; large-fibre: vibration/proprioception). Referral letters specify the suspected subtype and whether atypical features warrant further investigation.

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

Chronic hyperglycaemia drives nerve injury through several converging mechanisms. Increased flux through the polyol pathway leads to sorbitol and fructose accumulation, with osmotic and redox consequences. Formation of advanced glycation end products (AGEs) and activation of their receptors promote oxidative stress and inflammatory signalling. Activation of protein kinase C and the hexosamine pathway further contributes to neuronal and Schwann cell dysfunction. Microvascular changes, including endothelial dysfunction and nerve ischaemia, impair nutrient supply to nerves. These metabolic and vascular insults combine to produce axonal degeneration, demyelination, and impaired nerve regeneration, most pronounced in the longest nerves and therefore manifesting in a length-dependent distribution.

PRIMARY CAUSES

Chronic hyperglycaemia

Sustained elevated glucose drives polyol pathway flux, AGE formation, oxidative stress, and microvascular injury, producing cumulative peripheral nerve damage.

Cardiovascular risk factors (hypertension, dyslipidaemia, obesity)

These factors contribute to nerve ischaemia and endothelial dysfunction, accelerating and amplifying hyperglycaemia-induced nerve injury.

Type 1 diabetes mellitus

Autoimmune insulin deficiency leads to chronic hyperglycaemia; neuropathy risk is strongly related to glycaemic exposure over time.

Type 2 diabetes mellitus

Insulin resistance and chronic hyperglycaemia, often accompanied by obesity, hypertension, and dyslipidaemia, create a metabolic and vascular milieu that injures peripheral nerves.

Prediabetes

Even sub-diabetic hyperglycaemia can produce nerve injury through the same metabolic pathways, although the risk and severity are lower than in established diabetes.

🌍

Epidemiology

Prevalence:Pooled global prevalence of diabetic peripheral neuropathy among people with diabetes is approximately 36%, with higher estimates (up to 50%) in clinic-based populations; prevalence is higher in developing than in developed settings.

Age Group:Risk increases with longer diabetes duration and poorer glycaemic control; it affects adults across the lifespan, with the highest burden in middle-aged and older adults with long-standing type 2 diabetes, and in those with type 1 diabetes of long duration.

Sex Predilection:Equal

Geographic Distribution:Diabetic peripheral neuropathy is more prevalent in developing countries (pooled prevalence around 39%) than in developed countries (around 25%), in part reflecting differences in diabetes control, healthcare access, and detection methods.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 URGENT

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

Loss of protective sensation on 10 g monofilament testing — raises concern for imminent risk of foot ulceration and amputation; ensure urgent foot care education, protective footwear, and podiatry referral.
Atypical features such as rapid onset, marked asymmetry, motor predominance, or proximal involvement — should prompt evaluation for alternative causes (e.g., CIDP, malignancy, monoclonal gammopathy, vitamin B12 deficiency) rather than assuming diabetic neuropathy.
Signs of Charcot neuroarthropathy (unilateral red, hot, swollen foot without infection) — requires urgent offloading and specialist assessment to prevent progressive deformity and amputation.

URGENT EVALUATION TRIGGERS

New foot ulcer, blister, or skin breakdown in a person with known loss of protective sensation
Rapidly progressive weakness or sensory loss, or proximal/asymmetric involvement
Signs of autonomic dysfunction such as orthostatic hypotension with syncope or resting tachycardia
Unilateral red, hot, swollen foot suggestive of acute Charcot neuroarthropathy

Contraindications & Precautions

SPECIAL PRECAUTIONS

Perform annual comprehensive foot examination
including 10 g monofilament and at least one other sensory modality
to identify loss of protective sensation before ulceration occurs.
Do not attribute neuropathy to diabetes until other treatable causes (e.g.
vitamin B12 deficiency
alcohol-related neuropathy
monoclonal gammopathy) have been reasonably excluded.
When prescribing pharmacotherapy for painful diabetic neuropathy
assess for comorbidities and contraindications specific to the chosen agent (e.g.
renal function for gabapentinoids
hepatic function and cardiovascular risk for duloxetine).

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Diabetic foot ulceration — loss of protective sensation allows unrecognised trauma and pressure injury
leading to skin breakdown
Lower-limb amputation — often preceded by foot ulceration and infection
Charcot neuroarthropathy — progressive bone and joint destruction in the setting of neuropathy
causing deformity and increasing ulceration risk
Cardiovascular autonomic neuropathy — associated with increased cardiovascular mortality and risk of sudden death
Autonomic dysfunction affecting gastrointestinal
genitourinary
and sudomotor function — can cause gastroparesis
erectile dysfunction
and impaired sweating

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

Diabetic Nephropathy

Sounds similar; nephropathy refers to kidney disease, not nerve disease. Confusion can lead to incorrect documentation of the affected organ system.

Diabetic Retinopathy

Similar prefix and rhythm; retinopathy refers to retinal disease. These are distinct microvascular complications that require separate screening and management.

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

Vitamin B12 deficiency neuropathy

Key Distinguishing Feature: Macrocytic anaemia, low serum B12, elevated methylmalonic acid; may coexist with diabetes, especially in metformin users, and requires specific replacement.

Alcohol-related neuropathy

Key Distinguishing Feature: History of chronic alcohol misuse; often mixed large- and small-fibre, may improve with abstinence and thiamine supplementation; a common alternative cause of length-dependent neuropathy.

Chronic inflammatory demyelinating polyneuropathy (CIDP)

Key Distinguishing Feature: Proximal weakness, areflexia, elevated cerebrospinal fluid protein, and demyelinating features on nerve conduction studies; potentially treatable with immunotherapy.

Monoclonal gammopathy-associated neuropathy

Key Distinguishing Feature: Serum protein electrophoresis with immunofixation identifies a monoclonal protein; may require haematological evaluation and specific treatment.

💎

Clinical Pearls

💎

Diabetic peripheral neuropathy is a diagnosis of exclusion: up to 50% of cases may be asymptomatic, and other treatable causes of neuropathy must be considered, especially when features are atypical.

💎

The 10 g monofilament identifies loss of protective sensation and predicts ulceration risk, but it does not reliably detect early neuropathy; combine it with vibration perception (128 Hz tuning fork) and small-fibre testing (pinprick or temperature).

💎

Cardiovascular autonomic neuropathy carries a poor prognosis, with increased cardiovascular mortality and risk of sudden death; it should be actively sought in patients with other microvascular complications.

💎

Optimal glycaemic control prevents or delays diabetic peripheral neuropathy in type 1 diabetes and may modestly slow progression in type 2 diabetes, but it does not reverse established nerve loss.

📝

Example Usage & SOAP

CLINICAL SENTENCE

""Annual foot screening revealed absent 10 g monofilament sensation bilaterally and reduced vibration perception at the great toes, consistent with diabetic peripheral neuropathy; the patient was advised on protective footwear and podiatry follow-up.""

IN A SOAP NOTE

S: A 58-year-old man with type 2 diabetes of 12 years reports intermittent burning and numbness in both feet. O: Foot examination shows reduced pinprick and temperature sensation in a stocking distribution to mid-shin bilaterally; 10 g monofilament sensation absent at both great toes; ankle reflexes absent; vibration perception reduced at the great toes. A: Diabetic peripheral neuropathy (distal symmetrical polyneuropathy) with loss of protective sensation. P: Optimise glycaemic control; screen for vitamin B12 deficiency; commence foot care education and protective footwear; refer to podiatry; consider pharmacotherapy if pain becomes disabling.

DIFFERENTIAL DIAGNOSIS CONTEXT

Differential for distal symmetrical polyneuropathy in a person with diabetes: (1) diabetic peripheral neuropathy — length-dependent, symmetrical, associated with retinopathy or nephropathy; (2) vitamin B12 deficiency — check B12 and methylmalonic acid, especially in metformin users; (3) alcohol-related neuropathy — obtain detailed alcohol history; (4) monoclonal gammopathy — serum protein electrophoresis with immunofixation; (5) CIDP — consider if proximal weakness, areflexia, or rapid progression; nerve conduction studies if atypical.

📊

Classifications & Scoring

GRADING SYSTEM

Toronto Clinical Neuropathy Score (TCNS)

A clinical scoring system for diabetic sensorimotor polyneuropathy that combines symptom scores, reflex scores, and sensory test scores (pinprick, temperature, light touch, vibration, position). Total score ranges 0–19; 0–5 indicates no neuropathy, 6–8 mild, 9–11 moderate, and 12–19 severe neuropathy.

View Reference ↗

SCORING TOOL

Michigan Neuropathy Screening Instrument (MNSI)

A two-part instrument comprising a 15-item symptom questionnaire and a foot examination (appearance, ulceration, ankle reflexes, vibration perception). A foot examination score of ≥2 is considered positive for diabetic peripheral neuropathy.

Clinical Calculator ↗

📈

Prognosis

SHORT-TERM OUTCOME

Short-term prognosis depends on the subtype; painful symptoms may fluctuate, and foot ulceration can progress rapidly if protective sensation is lost and preventive care is not implemented.

LONG-TERM PROGNOSIS

Diabetic peripheral neuropathy is generally progressive and irreversible; it is associated with approximately a twofold higher mortality compared with people with diabetes without neuropathy, and cardiovascular autonomic neuropathy is linked to increased cardiovascular mortality.

📚

References & Coding

LITERATURE CITATIONS & GUIDELINES

[1]American Diabetes Association Professional Practice Committee. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S252–S265.

[2]Ziegler D, Keller J, Maier C, Pannek J. Diabetische Neuropathie. Diabetol Stoffwechs. 2025;20:S332–S346. doi:10.1055/a-2592-8568

[3]Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154.

[4]Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8–14.

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.